四种自动化临床分析仪检测总25(OH)D与认证LC-MS/MS的比较评价
该研究用124份血清样本在五种方法(LC-MS/MS参考方法、Cascadion、Lumipulse、Roche Elecsys II和III)上检测总25(OH)D,并依据Milan模型1和2评价分析性能。Cascadion正确分类患者比例最高(95.2%),且不受高浓度3-epi-25(OH)D3影响,而三种免疫法均受影响。
要点
- Cascadion正确分类患者比例达95.2%,高于三种免疫法。
- Lumipulse和Roche Elecsys III偏倚达optimal标准,Cascadion达desirable标准。
- Roche Elecsys II未达minimal偏倚标准。
核心结论
- 与LC-MS/MS参考方法相比,Cascadion在总25(OH)D医学决策cut-off处一致性最高,偏倚达desirable标准。
- 3-epi-25(OH)D3仅对免疫法造成干扰,Roche Elecsys方法尤为明显。
研究设计与样本
- 共124份血清样本,在五种方法上检测:参考LC-MS/MS、Cascadion、Lumipulse、Roche Elecsys II和Roche Elecsys III。
- 依据Milan模型1(基于临床结局,阈值12、20和30 ng/mL)和模型2(基于生物学变异)评价分析性能,并进行不精密度研究和NIST SRM972a样本准确度验证。
主要发现
- Lumipulse和Roche Elecsys III偏倚达optimal标准,Cascadion达desirable标准,Roche Elecsys II未达minimal标准。
- Cascadion正确分类患者比例(95.2%)高于三种免疫法。
- Cascadion精密度更优,且不受高浓度3-epi-25(OH)D3影响;三种免疫法均受影响,Roche Elecsys方法尤甚。
关键数值与推荐
- Milan模型1使用阈值12、20和30 ng/mL评价基于临床结局的分析性能。
- Milan模型2基于生物学变异评价分析性能。
临床怎么用
- 高性能全自动质谱法(如Cascadion)有助于LC-MS/MS在非专科临床实验室的广泛采用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study was to compare the results of five methods for the determination of total 25(OH)D. For that purpose, two mass spectrometry and three immunoassay methods were used. METHODS: A total of 124 serum samples were analyzed on five different methods (i.e., a reference LC-MS/MS, Cascadion, Lumipulse, Roche Elecsys II and Roche Elecsys III). Analytical performance against LC-MS/MS was evaluated and compared to the Milan models 1 (analytical performance based on the clinical outcome using thresholds of 12, 20 and 30 ng/mL) and 2 (analytical performance based on biological variation). Additionally, imprecision studies and accuracy using NIST SRM972a samples were carried out. RESULTS: Compared to the reference LC-MS/MS method, the Lumipulse and the Roche Elecsys III assays reached the optimal criterion for bias, while the Cascadion met the desirable one. The Roche Elecsys II was not able to reach the minimal criteria. The proportion of correctly classified patients was higher using the Cascadion (95.2%) compared to the three immunoassays. In addition to its better precision, the Cascadion was not impacted by a high concentration of 3-epi-25(OH)D3 compared to the three immunoassays. CONCLUSIONS: Compared to the LC-MS/MS reference method, the Cascadion presented the highest level of concordance at medical decision cut-offs for total 25(OH)D and reached the desirable specification for bias. Moreover, the presence of 3-epi-25(OH)D3 in enriched samples was only problematic in immunoassay methods, and especially considering Roche Elecsys methods. The release of performant fully automated mass spectrometry assays with high throughput might therefore facilitate the wide scale adoption of LC-MS/MS, even in non-specialized clinical laboratories.
引用
- Favresse J, Fangazio M, Cotton F, et al. Evaluation of four automated clinical analyzers for the determination of total 25(OH)D in comparison to a certified LC-MS/MS. Clin Chem Lab Med. 2023. PMID: 36785905. doi:10.1515/cclm-2022-1129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。